Mustang Bio, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 51.6 million compared to USD 77.53 million a year ago. Basic loss per share from continuing operations was USD 6 compared to USD 10.09 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3178 USD | +8.46% | +0.54% | -76.46% |
May. 02 | Mustang Bio, Inc. announced that it has received $3.3 million in funding | CI |
Apr. 30 | Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants | MT |
1st Jan change | Capi. | |
---|---|---|
-76.46% | 3.69M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023